Norfloxacin
From Wikipedia, the free encyclopedia
 |
|
|
Norfloxacin
|
|
| Systematic (IUPAC) name | |
| 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1H-quinoline- 3-carboxylic acid |
|
| Identifiers | |
| CAS number | |
| ATC code | J01 S01AX12 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C16H18FN3O3 |
| Mol. mass | 319.331 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | 3 to 4 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Norfloxacin is an oral broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections. It is also sometimes used to treat stomach infections.
[edit] Mechanism of action
The mechanism of action of norfloxacin involves inhibition of the A subunit of bacterial DNA gyrase, an enzyme which is essential for DNA replication.[1]
[edit] References
- ^ Goldstein E (1987). "Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity". Am J Med 82 (6B): 3–17. doi:. PMID 3111257.
|
|||||||||||
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
